Dec 7, 2018
|
8:00am - 9:00am
Rounds
City-Wide Endocrinology Rounds
Title: "Should Metformin Remain First-Line Therapy?"
Speaker: Dr. Alice Cheng, Staff Endocrinologist, St. Michael's Hospital & Trillium Health Partners; Associate Professor, University of Toronto
Learning Objectives:
At the end of this session, the participant should be able to:
- Explain the rationale for metformin's current position in the management of T2D
- Justify alternative options for first-line
- Decide for yourself what should be first-line
Host: Dr. Jackie James